Profound Medical Corp Stock Performance
| PROF Stock | USD 6.14 0.11 1.76% |
The company holds a Beta of 0.13, which implies not very significant fluctuations relative to the market. As returns on the market increase, Profound Medical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Profound Medical is expected to be smaller as well. At this point, Profound Medical Corp has a negative expected return of -0.45%. Please make sure to check Profound Medical's total risk alpha, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Profound Medical Corp performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Profound Medical Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders. ...more
| Begin Period Cash Flow | 46.5 M |
Profound |
Profound Medical Relative Risk vs. Return Landscape
If you would invest 816.00 in Profound Medical Corp on November 9, 2024 and sell it today you would lose (202.00) from holding Profound Medical Corp or give up 24.75% of portfolio value over 90 days. Profound Medical Corp is currently does not generate positive expected returns and assumes 2.4561% risk (volatility on return distribution) over the 90 days horizon. In different words, 21% of stocks are less volatile than Profound, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Profound Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Profound Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Profound Medical Corp, and traders can use it to determine the average amount a Profound Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1837
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | PROF |
Estimated Market Risk
| 2.46 actual daily | 21 79% of assets are more volatile |
Expected Return
| -0.45 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.18 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Profound Medical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Profound Medical by adding Profound Medical to a well-diversified portfolio.
Profound Medical Fundamentals Growth
Profound Stock prices reflect investors' perceptions of the future prospects and financial health of Profound Medical, and Profound Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Profound Stock performance.
| Return On Equity | -0.9 | ||||
| Return On Asset | -0.45 | ||||
| Operating Margin | (3.17) % | ||||
| Current Valuation | 165.73 M | ||||
| Shares Outstanding | 30.03 M | ||||
| Price To Book | 6.04 X | ||||
| Price To Sales | 20.89 X | ||||
| Revenue | 7.2 M | ||||
| EBITDA | (26.78 M) | ||||
| Cash And Equivalents | 46.21 M | ||||
| Cash Per Share | 2.21 X | ||||
| Total Debt | 7.94 M | ||||
| Debt To Equity | 0.02 % | ||||
| Book Value Per Share | 1.26 X | ||||
| Cash Flow From Operations | (22.3 M) | ||||
| Earnings Per Share | (1.34) X | ||||
| Total Asset | 43.91 M | ||||
| Retained Earnings | (217.93 M) | ||||
| Current Asset | 9 K | ||||
| Current Liabilities | 761 K | ||||
About Profound Medical Performance
By analyzing Profound Medical's fundamental ratios, stakeholders can gain valuable insights into Profound Medical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Profound Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Profound Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Profound Medical Corp. is headquartered in Mississauga, Canada. Profound Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 146 people.Things to note about Profound Medical Corp performance evaluation
Checking the ongoing alerts about Profound Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Profound Medical Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Profound Medical generated a negative expected return over the last 90 days | |
| The company reported the previous year's revenue of 7.2 M. Net Loss for the year was (28.57 M) with profit before overhead, payroll, taxes, and interest of 5.57 M. | |
| Profound Medical Corp currently holds about 46.21 M in cash with (22.3 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.21. |
- Analyzing Profound Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Profound Medical's stock is overvalued or undervalued compared to its peers.
- Examining Profound Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Profound Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Profound Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Profound Medical's stock. These opinions can provide insight into Profound Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Profound Stock analysis
When running Profound Medical's price analysis, check to measure Profound Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Profound Medical is operating at the current time. Most of Profound Medical's value examination focuses on studying past and present price action to predict the probability of Profound Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Profound Medical's price. Additionally, you may evaluate how the addition of Profound Medical to your portfolios can decrease your overall portfolio volatility.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |